ici 215001 has been researched along with phenylbutazone in 1 studies
| Studies (ici 215001) | Trials (ici 215001) | Recent Studies (post-2010) (ici 215001) | Studies (phenylbutazone) | Trials (phenylbutazone) | Recent Studies (post-2010) (phenylbutazone) |
|---|---|---|---|---|---|
| 8 | 0 | 2 | 6,291 | 317 | 125 |
| Protein | Taxonomy | ici 215001 (IC50) | phenylbutazone (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 5.3 | |
| Cyclooxygenase-2 | Canis lupus familiaris (dog) | 3.79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, P; Law, B; Malone, MD | 1 |
1 other study(ies) available for ici 215001 and phenylbutazone
| Article | Year |
|---|---|
The use of competitive displacement agents to resolve albumin binding problems observed during the development of a radioimmunoassay for ICI 215001.
Topics: Adrenergic beta-Agonists; Animals; Antibody Specificity; Binding, Competitive; Calibration; Chromatography, Gel; Humans; Hydrogen-Ion Concentration; Phenoxyacetates; Phenylbutazone; Protein Binding; Radioactive Tracers; Radioimmunoassay; Sensitivity and Specificity; Serum Albumin; Sheep; Warfarin | 1994 |